Navigation Links
MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen

SE) and conference proceedings were searched (1990-2005). The study included full-text and abstract publications. Number needed to treat (NNT) were calculated to facilitate interpretation.

About MabThera

MabThera is a therapeutic antibody that binds to a particular protein - the CD20 antigen - on the surface of normal and malignant B-cells. It then recruits the body's natural defences to attack and kill the marked B-cells. Stem cells (B-cell progenitors) in bone marrow lack the CD20 antigen, allowing healthy B-cells to regenerate after treatment and return to normal levels within several months.

MabThera is indicated for the treatment of indolent and aggressive Non-Hodgkin's Lymphoma. MabThera is known as Rituxan in the United States, Japan and Canada. To date, patients have received more than 1 million treatments with MabThera worldwide.

Genentech and Biogen Idec co-market MabThera in the United States, and Roche markets MabThera in the rest of the world, except Japan, where MabThera is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the Pharmaceuticals Division totalled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 worldwide and has R&D a
'"/>




Page: 1 2 3 4

Related medicine technology :

1. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
2. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Post Your Comments:
(Date:9/1/2015)... 1, 2015 Agena Bioscience TM today announced ... , a commercial and financial hub from which many biotech ... testing laboratories in mainland China . ... Bioscience,s global sales with almost sixty MassARRAY ® Systems ... will allow us to expand our reach and foster ...
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ... "Introduction to Veterinary Pharmacovigilance (London, UK - September ... This course has been designed to provide ... concerned with Veterinary Pharmacovigilance. New entrants, support staff ... better understanding of veterinay drug safety will benefit ...
Breaking Medicine Technology:Agena Bioscience Opens Office in Shanghai, China 2SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
(Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value ... years ago. A pilot program begun by the company in 2014 has proved popular ... on pursuing careers in these fields. The program is now open to area middle ...
(Date:9/1/2015)... York (PRWEB) , ... September 01, 2015 , ... Zecurion, ... Zlock Mac , its groundbreaking new version of endpoint DLP developed specifically for Mac ... Mac, in which more than 100 IT and information security professionals had participated. The ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, local food access, and ... be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference : “Innovation and the ... , In addition to keynotes Pierre Sleiman, founder and CEO of Go Green Agriculture, ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
(Date:9/1/2015)... ... 01, 2015 , ... The PracticeMatch Career Fair ... the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, IN 46225. More than ... the country. All specialties will be represented. Attendees will enjoy free hors d’oeuvres ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4
... Quarter Revenue up 29% to $50.4 Million Strong ... Full Year Revenue Growth of 17% to ... Feb. 28 Cardiac Science,Corporation (Nasdaq: CSCX ), ... informatics products, today announced,record results for the fourth quarter ...
... Robert Leonard, Founder and,Chief Surgeon of Leonard Hair Transplant ... the availability of a new genetic test for male,pattern ... New England to,offer this to patients., Dr. Robert ... be,affected by genetic male pattern baldness. This exciting new ...
... of the patent office "non-final" decision on a human ... Foundation (WARF),shows the following gains made for researchers:, ... was underserved,and new amended claims have been narrowed., ... no matter how,they are derived, but the amended "non-final" ...
... of two cellular receptors that likely contribute to the genesis ... targeted therapies against the disease, says a team led by ... , The finding also helps explain how daily use of ... at bay. , "These two receptors, called EP2 and EP4, ...
... Their U.S. Representative if they Support,Administration,s Medicare Cuts, ... to,begin debate on the Bush Administration,s proposed FY ... nursing home benefit,a new national survey conducted by ... finds 63 percent of likely voters oppose the,cut ...
... Missouri scientist Kattesh Katti recently discovered how to ... water. Kattis research has garnered attention worldwide and ... several disciplines. , Gold nanoparticles are tiny pieces ... by the naked eye. Researchers believe gold nanoparticles ...
Cached Medicine News:Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 2Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 3Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 4Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 5Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 6Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 7Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 8Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 9Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 10Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 11Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 12Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 14Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 15Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 16Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 17Health News:Dr. Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 2Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 3Health News:New National Poll: Majority of American Voters Oppose Bush Administration's Proposed Cuts to Medicare 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
Medicine Products: